Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibition

•GCB-DLBCL insensitive to EZH2 inhibition become dependent on cholesterol synthesis.•This dependency relates to altered LDLR subcellular localization and LDL uptake.•EZH2 inhibition attenuates activation of SREBP2 targets. The methyltransferase EZH2 is a critical epigenetic writer in Germinal Center...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neoplasia (New York, N.Y.) Jg. 70; S. 101243
Hauptverfasser:	Niccolai, Rachele, Göbel, Camiel, Ndoj, Klevis, Kreft, Maaike, Kuiken, Hendrik J., Lieftink, Cor, Morris, Ben, Yska, Sietse D., Hendrix, Sebastian, van den Broek, Bram, Pappalardo, Vincent, Kersten, Marie José, Beijersbergen, Roderick L., Zelcer, Noam, van Leeuwen, Fred, Jacobs, Heinz
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 01.12.2025 Elsevier
Schlagworte:	Animals Antineoplastic Agents - pharmacology Cell Line, Tumor Cholesterol - biosynthesis CRISPR-Cas9 screen Diffuse large B cell lymphoma Enhancer of Zeste Homolog 2 Protein - antagonists & inhibitors Enhancer of Zeste Homolog 2 Protein - genetics Enhancer of Zeste Homolog 2 Protein - metabolism EZH2 Humans LDL-receptor Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - genetics Lymphoma, Large B-Cell, Diffuse - metabolism Lymphoma, Large B-Cell, Diffuse - pathology Mice Oncology Receptors, LDL - metabolism Xenograft Model Antitumor Assays Diffuse large B cell lymphoma Cholesterol Biosynthesis LDL-receptor CRISPR-Cas9 screen EZH2
ISSN:	1476-5586, 1476-5586
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!